We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
QALSODY Biogen Australia Pty Ltd
Product name
QALSODY
Sponsor
Accepted date
Jan-2025
Active ingredients
tofersen
Proposed indication
QALSODY is used to treat amyotrophic lateral sclerosis that is linked to a mutation in the SOD1 gene.
Application type
A (new medicine)
Publication date
Jan-2025
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.